TY - JOUR
T1 - Nε functionalization of metal and organic protected L-histidine for a highly efficient, direct labeling of biomolecules with [Tc(OH2)3(CO)3]+
AU - Pak, Jae Kyoung
AU - Benny, Paul
AU - Spingler, Bernhard
AU - Ortner, Kirstin
AU - Alberto, Roger
PY - 2003/5/9
Y1 - 2003/5/9
N2 - Two different pathways for the introduction of an acetyl group at Nε in a Nα, Nδ, and -COO protected histidine to afford Nε-(CH2COOH)-histidine derivative 7b are presented. The purpose of this study is the coupling of 7b to amino groups in bioactive molecules such as peptides. After full deprotection of such a bioconjugate, histidine provides three coordination sites which efficiently coordinate to [99mTc(OH2)3-(CO)3]+ or [Re(OH2)3(CO)3]+ in a facial geometry. This allows the development of novel radiopharmaceuticals. Selective derivatization at the Nε position has conveniently been achieved by concomitant protection of Nα and Nδ with a carbonyl group forming a six-membered urea. Cyclic urea ring opening with Fm-OH, coupling of phenylalanine as a model to 7b through its primary amine and removing of all protecting groups in one step gave a histidine derivative of phenylalanine which could be labeled at 10-5M with 99mTc in very high yield and even in about 50% yield at 10-6M. The X-ray structure of a complex with [Re-(CO)3]+ in which anilin is coupled to 7b confirms the facial arrangement of histidine. A second pathway applies directly the [Re(CO)3]+ moiety as a protecting group. This is one of the rare examples in which a metal fragment is used as a protecting group for organic functionalities. The coordination to histidine protects the Nα, Nδ and COO group in one single step, subsequent alkylation with BrCH2COOH(R) at Nε, coupling to phenylalanine and oxidative deprotection of [Re(CO)3]+ to [ReO4]- gave the corresponding bioconjugate in which histidine is coupled to phenylalanine through an acetylamide at Nε. Both methods offer convenient pathways to introduce histidine in a biomolecule under retention of its three coordination sites. The procedures are adaptable to any biomolecule with pendant amines and allow the development of novel radiopharmaceuticals or inversed peptides.
AB - Two different pathways for the introduction of an acetyl group at Nε in a Nα, Nδ, and -COO protected histidine to afford Nε-(CH2COOH)-histidine derivative 7b are presented. The purpose of this study is the coupling of 7b to amino groups in bioactive molecules such as peptides. After full deprotection of such a bioconjugate, histidine provides three coordination sites which efficiently coordinate to [99mTc(OH2)3-(CO)3]+ or [Re(OH2)3(CO)3]+ in a facial geometry. This allows the development of novel radiopharmaceuticals. Selective derivatization at the Nε position has conveniently been achieved by concomitant protection of Nα and Nδ with a carbonyl group forming a six-membered urea. Cyclic urea ring opening with Fm-OH, coupling of phenylalanine as a model to 7b through its primary amine and removing of all protecting groups in one step gave a histidine derivative of phenylalanine which could be labeled at 10-5M with 99mTc in very high yield and even in about 50% yield at 10-6M. The X-ray structure of a complex with [Re-(CO)3]+ in which anilin is coupled to 7b confirms the facial arrangement of histidine. A second pathway applies directly the [Re(CO)3]+ moiety as a protecting group. This is one of the rare examples in which a metal fragment is used as a protecting group for organic functionalities. The coordination to histidine protects the Nα, Nδ and COO group in one single step, subsequent alkylation with BrCH2COOH(R) at Nε, coupling to phenylalanine and oxidative deprotection of [Re(CO)3]+ to [ReO4]- gave the corresponding bioconjugate in which histidine is coupled to phenylalanine through an acetylamide at Nε. Both methods offer convenient pathways to introduce histidine in a biomolecule under retention of its three coordination sites. The procedures are adaptable to any biomolecule with pendant amines and allow the development of novel radiopharmaceuticals or inversed peptides.
KW - Bioorganometallic chemistry
KW - Histidine
KW - Radiopharmaceuticals
KW - Rhenium
KW - Technetium
UR - http://www.scopus.com/inward/record.url?scp=0038814032&partnerID=8YFLogxK
U2 - 10.1002/chem.200204445
DO - 10.1002/chem.200204445
M3 - Article
AN - SCOPUS:0038814032
SN - 0947-6539
VL - 9
SP - 2053
EP - 2061
JO - Chemistry - A European Journal
JF - Chemistry - A European Journal
IS - 9
ER -